Evidence map›Paper›PMID 41001673›Full record

ArticleFrontiers in endocrinology2025

Characterizing clinical risk profiles of major complications in type 2 diabetes mellitus using deep learning algorithms.

Haochen Liu, Xiaomiao Li, Ke Shi, Fengyu Lei, Ziyan Wang, Ziyuan Gao, Yunxi Liu, Jing Zhu, Jiajia Zhai, Yi Zhang and 5 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Haochen LiuDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Xiaomiao LiDepartment of Endocrinology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Ke ShiDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Fengyu LeiDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Ziyan WangDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Ziyuan GaoDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Yunxi LiuDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Jing ZhuDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Jiajia ZhaiDepartment of General Practice, Xi'an No.9 Hospital, Xi'an, Shaanxi, China.
Yi ZhangDepartment of General Practice, Xi'an No.9 Hospital, Xi'an, Shaanxi, China.
Xinyu LiDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Shiyu WangDepartment of Biological Sciences, Mellon College of Science, Carnegie Mellon University, Pittsburgh, PA, United States.
Yu NiuDepartment of Endocrinology, Xi'an No.9 Hospital, Xi'an, Shaanxi, China.
Louyan MaDepartment of General Practice, Xi'an No.9 Hospital, Xi'an, Shaanxi, China.
Tianxiao ZhangDepartment of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop a self-reportable risk assessment tool for elderly type 2 diabetes mellitus (T2DM) patients, evaluating risks of diabetic nephropathy (DN), retinopathy (DR), peripheral neuropathy (DPN), and diabetic foot (DF) using machine learning, thereby providing new insights and tools for the screening and intervention of these complications. Materials and methods: Data from 1,448 T2DM patients at Xi'an No.9 Hospital were used. After preprocessing, five machine learning algorithms (XGBoost, LightGBM, Random Forest, TabPFN, CatBoost) were applied. Models were trained on 70% of the data and evaluated on 30%, with performance assessed by multiple metrics and SHAP analysis for feature importance. Results: The analysis identified 33 risk factors, including 6 shared risk factors (UACR for DN and DR; diabetes duration for DR, DPN, and DF; IBILI for DF and DPN; history of DN for DR and DF; U-Cr for DR and DF; MCHC for DN and DPN) and 27 unique risk factors. Model performance was robust: for DN, TabPFN achieved an AUC of 0.905 and Random Forest an accuracy of 0.878; for DR, LightGBM attained an AUC of 0.794; for DPN, both TabPFN and CatBoost achieved a perfect recall of 1.000 and F1-score of 0.915; and for DF, LightGBM attaining the highest AUC of 0.704. SHAP analysis highlighted key features for each complication, such as UACR and Y-protein for DN, diabetes duration and TPOAB for DR, history of DN and IBILI for DF, and diabetes duration and SBP for DPN. Conclusion: This study employed interpretable machine learning to characterize risk factor profiles for multiple T2DM complications, identifying both common and distinct factors associated with major complications. The findings provide a foundation for exploring personalized risk management strategies and highlight the potential of data-driven approaches to inform early intervention research in T2DM complications.

Indexed as

AlgorithmsDeep LearningDiabetes ComplicationsDiabetes Mellitus, Type 2AgedDiabetic NephropathiesDiabetic NeuropathiesDiabetic RetinopathyFemaleHumansMaleMiddle AgedRisk AssessmentRisk Factorsdiabetic complicationsmachine learningrisk factorsSHAP (Shapley Additive explanation)Type 2 diabetes mellitus (T2DM)

Identifiers

PMID41001673
PMCPMC12457174

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.